HT
Hale Therapeutics
tryhale.com
Website unreachable since Oct 24, 2026
Hale has developed a digital drug therapy device that automatically adjusts nicotine intake over time, utilizing a patent-pending design to facilitate gradual de-addiction. This connected device, paired with a mobile app for usage tracking, addresses the challenge of nicotine addiction by providing a low-risk alternative to traditional cessation methods.
- Digital Health
- Hardware
- Healthcare Technology
- Internet of Things
Updated 7 months ago
Funding
Raised to date
$2.4MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Hale has developed a digital drug therapy device that automatically adjusts nicotine intake over time, utilizing a patent-pending design to facilitate gradual de-addiction. This connected device, paired with a mobile app for usage tracking, addresses the challenge of nicotine addiction by providing a low-risk alternative to traditional cessation methods.